Verzenio 150mg

$780.00

Verzenio 150mg is an oral medication that belongs to a class of drugs called CDK4/6 inhibitors. It is specifically indicated for the treatment of advanced or metastatic breast cancer that is hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), and has progressed despite endocrine therapy.